Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippi applies for you, and finds you a job.
Cambrex's peak revenue was $534.5M in 2017. The peak quarterly revenue was $182.3M in 2017(q4).
Cambrex's revenue increased from $249.2m in 2008 to $532.1M currently. That's a 113.5% change in annual revenue.
| Fiscal year / year | Cambrex revenue |
|---|---|
| 2009 | $234.6M |
| 2010 | $227.0M |
| 2011 | $255.7M |
| 2012 | $276.5M |
| 2013 | $318.2M |
| 2014 | $374.6M |
| 2015 | $433.3M |
| 2016 | $490.6M |
| 2017 | $534.5M |
| 2018 | $532.1M |
How accurately did Cambrex's revenue projections match actual performance?
Cambrex saw the greatest revenue growth in 2014, when revenue increased by 17.74%.
Cambrex had the lowest revenue growth in 2009, when revenue changed by -5.89%.
| Year | Cambrex growth |
|---|---|
| 2009 | -6%↓ |
| 2010 | -3%↓ |
| 2011 | 13%↑ |
| 2012 | 8%↑ |
| 2013 | 15%↑ |
| 2014 | 18%↑ |
| 2015 | 16%↑ |
| 2016 | 13%↑ |
| 2017 | 9%↑ |
| 2018 | -0%↓ |
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2009 | $61.0M | $59.3M | $56.4M | $57.9M |
| 2010 | $56.1M | $58.2M | $47.8M | $64.9M |
| 2011 | $60.6M | $68.4M | $59.2M | $67.5M |
| 2012 | $70.2M | $77.1M | $59.2M | $69.9M |
| 2013 | $74.9M | $62.8M | $77.5M | $103.0M |
| 2014 | $66.1M | $97.9M | $81.3M | $129.3M |
| 2015 | $77.5M | $106.6M | $93.0M | $156.2M |
| 2016 | $94.7M | $118.6M | $99.4M | $177.9M |
| 2017 | $105.0M | $134.6M | $112.6M | $182.3M |
| 2018 | $141.1M | $152.0M | $104.6M | $134.3M |
| 2019 | $159.5M | $176.9M | $148.6M | - |
Do you work at Cambrex?
Is Cambrex transparent about its revenue structure?
| CEO | Thomas Loewald |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 2,201 |
| Date Founded | 1981 |
| Headquarters | East Rutherford, New Jersey |
| Number of Locations | 6 |
| Revenue | $532.1M |
| Net Income | $92,418,000 |
| Gross Proft | $196.7M (2018) |
| PE Ratio | 17.21 |
| Tax Rate | 0.2% |
| Market Capitalization | $1.6B |
| Total Assets | $1,223,428,000 |
| Ticker | CBM |
Cambrex's top competitor, Merck, earned an annual revenue of $64.2B.
Cambrex's smallest competitor is Argos Therapeutics with revenue of $1.9M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| SIGA Technologies | $71,494 | $115.5M | 43 | 1 |
| Merck | $90,328 | $64.2B | 74,000 | 2,282 |
| United Therapeutics | $74,314 | $2.9B | 950 | 220 |
| Gilead Sciences | $99,828 | $28.8B | 11,800 | 707 |
| Alimera Sciences | $83,523 | $80.8M | 154 | - |
| Puma Biotechnology | $91,110 | $230.5M | 265 | 9 |
| Owens & Minor | $38,357 | $10.7B | 17,900 | 864 |
| Cambridge Major Laboratories, Inc. | $70,995 | $17.0M | 200 | - |
| Quidel | $71,489 | $1.7B | 1,500 | - |
| Alcami | $70,250 | $87.0M | 981 | 93 |
Zippia gives an in-depth look into the details of Cambrex, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Cambrex. The employee data is based on information from people who have self-reported their past or current employments at Cambrex. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Cambrex. The data presented on this page does not represent the view of Cambrex and its employees or that of Zippia.
Cambrex may also be known as or be related to CAMBREX CORP, Cambrex, Cambrex Corp. and Cambrex Corporation.